Ilaprazole

DB11964InvestigationalSmall molecule

Ilaprazole has been investigated in Helicobacter Infections.

Mechanism: Pharmacologically active on Potassium-transporting ATPase alpha chain 1, Lymphokine-activated killer T-cell-originated protein kinase, and Tumor susceptibility gene 101 protein
Curator reviewed
Formula / weight: C₁₉H₁₈N₄O₂S · 366.44 g/mol (avg)
Code names: IY-81149

Resolves to

Compound

UNII776Q6XX45JCAS172152-36-2ChEMBLCHEMBL2106370ChEBI135544PubChem214351

Clinical / RWD

ATCA02BC11PharmGKBPA165947499

Structure

InChIKeyHRRXCXABAPSOCP-UHFFFAOYSA-NSMILESCOC1=C(C)C(CS(=O)C2=NC3=C(N2)C=CC(=C3)N2C=CC=C2)=NC=C1

Targets

P20648ATP4AQ96KB5PBKQ99816TSG101

What you can answer from here — as of September 13, 2026

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

34Drug interactionsStructured to mechanism, not free text

29Clinical trialsPhase, status and sponsor resolved per trial

5Marketed productsAcross 2 countries and 3 labellers

1ATC codeIncluding every combination product, plus 16 drug categories

12+ReferencesStructured and connected to the statements they support

Which drugs share a target with Ilaprazole, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In